Stephen Brady
Fortune : 5 528 $ au 31/05/2026
Fortune : 5 528 $ au 31/05/2026
Mr. Stephen R.
Brady is an Independent Director at Atreca, Inc. and a Chairman at Tempest Therapeutics, Inc. He is on the Board of Directors at Biotechnology Innovation Organization and Atreca, Inc. Mr. Brady was previously employed as a President & Chief Operating Officer by Tempest Therapeutics, Inc. /Old/, an Executive Vice President-Strategy & Finance by Immune Design Corp., a Chief Business Officer by 3-V Biosciences, Inc., a Vice President-Corporate Development by Proteolix, Inc., a Senior Corporate Counsel by Lexicon Genetics, Inc., a Vice President-Venture Advisors by Lazard Frères & Co. LLC, and an Associate by Morrison & Foerster LLP.
He received his undergraduate degree from the University of Oregon, a graduate degree from the University of the Pacific and a graduate degree from New York University School of Law.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 3 613 ( 0,03% ) | 5 528 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Président | 03/02/2026 |
| ATRECA, INC. | Directeur/Membre du Conseil | 14/07/2021 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | 01/01/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | President | 01/06/2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 02/04/2019 |
| SAGIMET BIOSCIENCES INC. | Directeur des opérations | 11/02/2011 |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Conseiller Juridique Général | 25/03/2009 |
| LEXICON PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/2007 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
Lazard Frères & Co. LLC
Lazard Frères & Co. LLC Investment ManagersFinance Provides corporate advisory, capital market, and asset management services | Finance |
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Atreca, Inc.
Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of Oregon
University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Pacific
University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
New York University School of Law
New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national